DAX24.892 +0,1%Est505.932 +0,1%MSCI World4.343 -0,1%Top 10 Crypto12,36 -1,0%Nas23.547 +0,7%Bitcoin79.314 -1,0%Euro1,1692 ±0,0%Öl59,90 -1,0%Gold4.446 -1,1%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 DroneShield A2DMAA NVIDIA 918422 Novo Nordisk A3EU6F Infineon 623100 Lufthansa 823212 adidas A1EWWW RENK RENK73 Siemens Energy ENER6Y Bayer BAY001 Deutsche Telekom 555750 SAP 716460 Allianz 840400 Chevron 852552 ExxonMobil 852549
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX schließt höher als je zuvor -- Wall Street beendet Handel im Plus -- NVIDIA plant Robotaxis für 2027 -- DroneShield, adidas, Novo Nordisk, D-Wave, Rheinmetall, RENK, HENSOLDT, TKMS im Fokus
Top News
Blackout im Krypto-Sektor? So wären Bitcoin & Co. von einem Stromausfall betroffen Blackout im Krypto-Sektor? So wären Bitcoin & Co. von einem Stromausfall betroffen
Amazon-CEO Andy Jassy: Das ist sein Erfolgsgeheimnis Amazon-CEO Andy Jassy: Das ist sein Erfolgsgeheimnis
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Wer­bung
Verteidigung als Anlagechance: Mit diesem ETF erhältst du Zugang zu europäischen Unternehmen aus dem Luft-, Raumfahrt- und Verteidigungssektor.

West Pharmaceutical Services Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
240,80 EUR +3,60 EUR +1,52 %
BMN
280,79 USD +1,66 USD +0,60 %
BTT
West Pharmaceutical Services jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.17,17 Mrd. EUR

KGV49,00Div. Rendite0,25%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN864330

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS9553061055

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolWST

West Pharmaceutical Services Aktien News

DatumMeistgelesen
PR NewswireWest to Participate in Upcoming Investor Conference
PR NewswireWest Declares Quarterly Dividend
PR NewswireWest Synchrony™ Prefillable Syringe System Launches at CPHI: Redefining a system-level solution for drug delivery
Wer­bungWest Pharmaceutical Services-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireWest to Participate in Upcoming Investor Conferences
PR NewswireWest Reports Third-Quarter 2025 Results
PR NewswireWest to Host Third-Quarter 2025 Conference Call
PR NewswireWest to Participate in Upcoming Investor Conferences in September 2025
PR NewswireWest Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance
PR NewswireWest Welcomes Robert McMahon as Incoming Chief Financial Officer
PR NewswireWest to Host Second-Quarter 2025 Conference Call
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
PR NewswireWST Investors Have Opportunity to Lead West Pharmaceutical Services, Inc. Securities Fraud Lawsuit with the Schall Law Firm
PR NewswireWST Shareholders Have the Right to Lead the West Pharmaceutical Services, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - WST
PR NewswireSHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
PR NewswireThe Gross Law Firm Reminds West Pharmaceutical Services, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 - WST
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
PR NewswireThe Gross Law Firm Reminds West Pharmaceutical Services, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 - WST
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
PR NewswireWST Investors Have the Opportunity to Lead the West Pharmaceutical Services Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
PR NewswireContact The Gross Law Firm by July 7, 2025 Deadline to Join Class Action Against West Pharmaceutical Services, Inc.(WST)
PR NewswireWST Investors Have Opportunity to Lead West Pharmaceutical Services, Inc. Securities Fraud Lawsuit with the Schall Law Firm
PR NewswireONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
PR NewswireThe Gross Law Firm Notifies West Pharmaceutical Services, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - WST
PR NewswireWST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
PR NewswireWST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
PR NewswireWST INVESTOR NOTICE: West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
PR NewswireWST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
PR NewswireWest to Participate in Upcoming Investor Conferences
PR NewswireWST INVESTOR ALERT: West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead the West Pharmaceutical Class Action Lawsuit
PR NewswireWest Announces Leadership Changes
PR NewswireWest Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend
PR NewswireWest to Host First-Quarter 2025 Conference Call
PR NewswireWest to Participate in Upcoming Investor Conferences
PR NewswireWest Announces Second-Quarter Dividend

West Pharmaceutical Services News

West Pharmaceutical Services News: auf dieser Seite finden Sie alle West Pharmaceutical Services News und Nachrichten zur West Pharmaceutical Services Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch West Pharmaceutical Services News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um West Pharmaceutical Services News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.